IMPORTANT: This page is for research/educational use only. Ensure correct handling, sterile technique (for injectables), and appropriate measurement. If you are unsure, consult qualified professionals.
Methylene Blue (Oral)
Methylene blue (MB) is a redox-active phenothiazine compound studied for effects on mitochondrial electron transport, nitric oxide signaling, and methemoglobinemia reversal. In low doses it can act as an electron cycler supporting mitochondrial function; at higher doses it can become pro-oxidant. It is used in research on cognition, neuroprotection, and bioenergetics.
Dosing Protocols
- Low-dose research ranges often cited: ~0.5–2 mg/kg/day orally; some human cognition studies used single doses around 280 mg (protocol-specific)
- Many users stay in the 5–20 mg/day range for exploratory low-dose research; avoid chronic high-dose use
- Cycle length: days to weeks; include washouts and monitor for adverse effects
Benefits
- Supports mitochondrial electron transport/ATP production (dose-dependent)
- Investigated for cognitive and neuroprotective effects in preclinical and limited human studies
- Can reduce methemoglobin to hemoglobin in clinical contexts
- Modulates nitric oxide signaling (context-dependent)
- Has antimicrobial/antiparasitic properties (historical use)
Mechanism of Action
- Acts as a reversible redox carrier, shuttling electrons within the mitochondrial electron transport chain
- At low doses may reduce electron leak and oxidative stress; at higher doses can become pro-oxidant
- Inhibits soluble guanylate cyclase and can reduce NO-cGMP signaling
- Inhibits monoamine oxidase A at relevant concentrations (drug-interaction implication)
Side Effects
- Blue/green urine or stool; discoloration of saliva/teeth
- Nausea, abdominal discomfort
- Headache, dizziness
- Anxiety/agitation at higher doses
- Increased blood pressure (possible)
- Serotonin syndrome risk with serotonergic drugs
- Hemolysis risk in G6PD deficiency
Side Effect Management
- Avoid combining with SSRIs/SNRIs/MAOIs or other serotonergic agents without medical oversight
- Screen for G6PD deficiency before higher-dose exposure
- Use conservative dosing and discontinue if agitation, confusion, or tremor develops
- Take with food to reduce nausea
- Monitor blood pressure
Contraindications
- G6PD deficiency
- Concomitant serotonergic medications (risk of serotonin syndrome)
- Severe renal impairment (caution)
- Pregnancy/nursing
- Hypersensitivity
Research Citations
- Methylene blue as a therapeutic and experimental drug: mechanisms of action and clinical applications. Pharmacol Ther. PubMed | DOI
- Methylene blue enhances memory retention and increases cytochrome oxidase activity in brain. Neurobiol Aging. PubMed | DOI
- A randomized study of the effects of methylene blue on cerebral blood flow and memory. Radiology. PubMed | DOI
- Methylene blue in methemoglobinemia: pharmacology and clinical use. J Emerg Med. PubMed | DOI
IMPORTANT: This page is for research/educational use only. Ensure correct handling, sterile technique (for injectables), and appropriate measurement. If you are unsure, consult qualified professionals.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).